UNSPSC 51281616: Kanamycin

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RUC37XUP2P. European Medicines Agency schedules Kanamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08362MIG. Kanamycin generally arises in the molecular formula C18H36N4O11.

UNSPSC 51281616 Kanamycin is a Commodity code that nominally addresses a specific antibiotic product, but recent state and local solicitations tagged under this code predominantly seek broader pharmaceutical and medical supply procurement — particularly naloxone, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical consumables for first-responder and community health use. The actual buying patterns diverge significantly from the code's abstract designation; state and local buyers are using this code to capture diverse pharmaceutical and medical supply categories rather than kanamycin-specific acquisitions. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and multistate cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance). Geographic concentration appears strongest in Florida and Minnesota, with secondary activity in Texas, though the MMCAP cooperative vehicle extends reach to Oregon and other participating jurisdictions.

Recent opportunities span multiple procurement types and buying patterns. Seminole County, Florida released IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with a response deadline of July 26, 2023. The City of Tampa posted IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies (respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, gloves, bandaging materials) for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises including a 5 percent bid discount. Minnesota's cooperative purchasing alliance issued RFP S1070000015802 in January 2026 to establish multi-award contracts for generic pharmaceuticals and OTC products distributed across state and local facilities in multiple states, with proposals due March 26, 2026 and contract effectiveness scheduled for July 1, 2026. Texas HHS released RFI HHS0017013 in April 2026 as exploratory market intelligence on direct-to-manufacturer pharmacy prescriptions before issuing formal procurement solicitation. The mismatch between the code's nominal scope and actual recent buying activity suggests the code sees limited kanamycin-specific procurement at state and local level; instead, it functions as a catch-all for pharmaceutical and medical supply categories.